Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gap junction protein alpha 1 (GJA1), also known as Connexin 43 (Cx43), is a member of the connexin family and a key component of gap junctions. These junctions facilitate direct communication between cells by allowing the passage of ions, metabolites, and signaling molecules. Cx43 is crucial for coordinated cellular responses across tissues, especially in the heart for electrical impulse propagation. Dysregulation of GJA1 is linked to various disorders including craniometaphyseal dysplasia and congenital heart disease.
Forms gap junction channels facilitating direct cell-to-cell communication.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gap Junction Protein Alpha 1 (Cx43).